Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Andrzej Mogielnicki"'
Publikováno v:
Thrombosis Journal, Vol 21, Iss 1, Pp 1-14 (2023)
Abstract The assessment of hemostasis is necessary to make suitable decisions on the management of patients with thrombotic disorders. In some clinical situations, for example, during thrombophilia screening, the presence of anticoagulants in sample
Externí odkaz:
https://doaj.org/article/34d264d6e078401d892e2bda9e812fa5
Autor:
Joanna Miklosz, Bartlomiej Kalaska, Stanislaw Zajaczkowski, Dariusz Pawlak, Andrzej Mogielnicki
Publikováno v:
Pharmaceuticals, Vol 14, Iss 12, p 1223 (2021)
The methods used in preclinical studies should minimize the suffering and the number of animals but still provide precise and consistent results enabling the introduction of drug candidates into the phase of clinical trials. Thus, we aimed to develop
Externí odkaz:
https://doaj.org/article/09c2e028d3b5498da403bc68d4d7a6a7
Autor:
Joanna Miklosz, Bartlomiej Kalaska, Piotr Podlasz, Małgorzata Chmielewska-Krzesińska, Miłosz Zajączkowski, Adam Kosiński, Dariusz Pawlak, Andrzej Mogielnicki
Publikováno v:
Pharmaceutics, Vol 13, Iss 3, p 359 (2021)
Protamine sulfate (PS) is the only available option to reverse the anticoagulant activity of unfractionated heparin (UFH), however it can cause cardiovascular and respiratory complications. We explored the toxicity of PS and its complexes with UFH in
Externí odkaz:
https://doaj.org/article/7fc22af6465f41648ea4943778785950
Autor:
Joanna Miklosz, Bartlomiej Kalaska, Kamil Kaminski, Malgorzata Rusak, Krzysztof Szczubialka, Maria Nowakowska, Dariusz Pawlak, Andrzej Mogielnicki
Publikováno v:
Marine Drugs, Vol 17, Iss 9, p 539 (2019)
Protamine sulfate (PS) is a polycationic protein drug obtained from the sperm of fish, and is used to reverse the anticoagulant effect of unfractionated heparin (UFH). However, the interactions between PS, UFH, and platelets are still not clear. We m
Externí odkaz:
https://doaj.org/article/635bbaff01a04279946e6b03dce1bb9c
Autor:
Bartlomiej Kalaska, Kamil Kaminski, Emilia Sokolowska, Dominik Czaplicki, Monika Kujdowicz, Krystyna Stalinska, Joanna Bereta, Krzysztof Szczubialka, Dariusz Pawlak, Maria Nowakowska, Andrzej Mogielnicki
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0119486 (2015)
Protamine, the only registered antidote of unfractionated heparin (UFH), may produce a number of adverse effects, such as anaphylactic shock or serious hypotension. We aimed to develop an alternative UFH antidote as efficient as protamine, but safer
Externí odkaz:
https://doaj.org/article/5ddbab7f7d014d5cb8e4535beec460b0
Autor:
Marta Stolarek, Aleksandra Pycior, Piotr Bonarek, Małgorzata Opydo, Elzbieta Kolaczkowska, Kamil Kamiński, Andrzej Mogielnicki, Krzysztof Szczubiałka
Publikováno v:
Journal of Medicinal Chemistry. 66:1778-1789
Autor:
Bartlomiej Kalaska, Joanna Miklosz, Justyna Swieton, Aleksandra Jakimczuk, Dariusz Pawlak, Andrzej Mogielnicki
Publikováno v:
Vaccine. 40(13)
ChAdOx1 nCoV-19 adenoviral vector vaccine (ChAd) against coronavirus disease 2019 has been associated with vaccine-induced thrombosis and thrombocytopenia (VITT), especially in young women who have presented with unusual localized thrombosis after re
Autor:
Stanislaw Zajaczkowski, Bartlomiej Kalaska, Joanna Miklosz, Dariusz Pawlak, Andrzej Mogielnicki
Publikováno v:
Pharmaceuticals, Vol 14, Iss 1223, p 1223 (2021)
Pharmaceuticals; Volume 14; Issue 12; Pages: 1223
Pharmaceuticals
Pharmaceuticals; Volume 14; Issue 12; Pages: 1223
Pharmaceuticals
The methods used in preclinical studies should minimize the suffering and the number of animals but still provide precise and consistent results enabling the introduction of drug candidates into the phase of clinical trials. Thus, we aimed to develop
Autor:
Shin-ichi Yusa, Andrzej Mogielnicki, Dariusz Pawlak, Bartlomiej Kalaska, Krzysztof Szczubiałka, Joanna Miklosz, Justyna Swieton
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 20
International Journal of Molecular Sciences, Vol 22, Iss 11149, p 11149 (2021)
Volume 22
Issue 20
International Journal of Molecular Sciences, Vol 22, Iss 11149, p 11149 (2021)
Uncontrolled bleeding after enoxaparin (ENX) is rare but may be life-threatening. The only registered antidote for ENX, protamine sulfate (PS), has 60% efficacy and can cause severe adverse side effects. We developed a diblock copolymer, heparin-bind
Autor:
Aleksandra Jakimczuk, Bartlomiej Kalaska, Kamil Kamiński, Joanna Miklosz, Shin-Ichi Yusa, Dariusz Pawlak, Krzysztof Szczubiałka, Andrzej Mogielnicki
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 8; Pages: 2236
The routine monitoring of direct oral anticoagulants (DOACs) may be considered in patients with renal impairment, patients who are heavily obese, or patients requiring elective surgery. Using the heparin-binding copolymer (HBC) and polybrene, we aime